In This Story LLY -0.17% NVO +1.14% After revolutionizing the weight-loss drug market, Novo Nordisk ( NVO +1.14% ) and Eli Lilly ( LLY -0.17% ) are setting their sights on heart health. Suggested Reading The ETF strategy built to thrive during market volatility, according to a fund manager Stocks' worst hit from tariffs may be yet to come, strategist says Amazon wants its new AI agent to do stuff on the web for you Costco's Kirkland brand became a massive financial success. Here's how CC Share